NCT07326033: Efficacy and Safety of Allogenic Cultured Adipose-derived Mesenchymal Stromal Cell Injections on MoUth Fibrosis and Handicap in Patients With Systemic sclEroderma
- State
- Not started
- Phase
- Phase 2
- People
- 50 planned
- Started
- Jan 2026
- Primary completion
- 30 Apr 2028
- Arms
- AdMSC
- Results
- None posted
- 8 Jan 2026: Trial registered